Skip to main content
Braxia Scientific Corp. logo

Braxia Scientific Corp. — Investor Relations & Filings

Ticker · BRAX CSE Human health and social work activities
Filings indexed 182 across all filing types
Latest filing 2022-09-30 Regulatory Filings
Country CA Canada
Listing CSE BRAX

About Braxia Scientific Corp.

www.braxiascientific.com

Braxia Scientific Corp. is a research-driven medical solutions company dedicated to reducing the illness burden of brain-based mental disorders, including major depressive disorder. The company operates Braxia Health, a network of multidisciplinary clinics specializing in psychedelic therapy and providing innovative, science-backed ketamine treatments for depression and related conditions. Braxia Scientific actively leads novel psychedelic research, conducting clinical trials (e.g., Phase II studies of psilocybin-assisted therapy for treatment-resistant depression). Additionally, the company develops proprietary ketamine and psilocybin derivatives and other psychedelic products via its intellectual property development platform.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings
2022-09-30 English
Form of proxy - English.pdf
Regulatory Filings
2022-09-30 English
Management information circular - English.pdf
Regulatory Filings
2022-09-30 English
News release - English.pdf
Regulatory Filings
2022-09-22 English
News release - English.pdf
Regulatory Filings
2022-09-17 English
News release - English.pdf
Regulatory Filings
2022-09-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.